LIVN - LivaNova starts targeted commercial launch of Essenz Patient Monitor for heart & lung bypass

Medical device maker LivaNova (NASDAQ:LIVN) started a targeted commercial launch for its Essenz Patient Monitor after receiving required regulatory approvals. According to the company, the monitoring system improves clinical efficiency by displaying data and parameters to patients through an intuitive graphical user interface during cardiopulmonary bypass procedures. The monitor is now in clinical use in select centers in the U.S. and Europe. The monitor will be a key feature of the company's Essenz Perfusion System, which is currently under development and is expected to launch in stages later this year.

For further details see:

LivaNova starts targeted commercial launch of Essenz Patient Monitor for heart & lung bypass